The
recombinant DNA technology has revolutionized the field of molecular biology.
重组DNA技术彻底改变了分子生物学领域。
Scientists successfully created a
recombinant vaccine by combining parts of different virus strains.
科学家成功通过组合不同病毒株的部分片段制造出了一种重组疫苗。
This
recombinant protein is used in clinical trials to treat a rare genetic disorder.
这种重组蛋白质在临床试验中被用于治疗一种罕见的遗传疾病。
Recombinant insulin, produced in bacteria, has been crucial for treating diabetes.
在细菌中生产的重组胰岛素对糖尿病的治疗至关重要。
The expression of the
recombinant gene was confirmed through a series of biochemical assays.
通过一系列生化实验确认了重组基因的表达。
Using
recombinant techniques, we can insert a human gene into the genome of an animal model.
利用重组技术，我们可以将人源基因插入动物模型的基因组中。
The
recombinant plasmid was introduced into mammalian cells for further study.
重组质粒被导入哺乳动物细胞以进行进一步研究。
Researchers were able to isolate and purify the
recombinant enzyme from the cell culture.
研究人员能够从细胞培养物中分离并纯化出重组酶。
A
recombinant form of the hormone was synthesized in order to enhance its stability and effectiveness.
为了提高其稳定性和有效性，研究人员合成了该激素的重组形式。
The development of
recombinant growth factors has greatly advanced tissue engineering research.
重组生长因子的发展极大地推动了组织工程学的研究。
Another set of systems can effectively support production not only in traditional areas such as antibodies, vaccines, recombinant proteins and blood products but also for emerging therapeutics like plasmids, viral vectors and nucleic acids.
另一套系统不仅可以有效支持抗体、疫苗、重组蛋白和血液制品等传统领域的生产，还可以有效支持质粒、病毒载体和核酸等新兴疗法的生产。
Coincidentally, after Japanese cosmetics company Shiseido established its fund company in China in May 2022, the first enterprise that it invested in was Jiangsu Trautec Medical Technology Co Ltd, a local company that focuses on the development and production of recombinant collagen-based biomaterials.
无独有偶，日本化妆品公司资生堂于2022年5月在中国成立基金公司后，其投资的第一家企业是江苏特劳泰克医疗技术有限公司，这是一家专注于开发和生产重组胶原蛋白生物材料的本土公司。
In January 2022, the National Medical Products Administration issued an industrial standard for recombinant collagen, a subcategory of collagen that is widely used in the medical aesthetics sector, specifying its quality control requirements, test indicators, test methods and biological evaluation.
2022年1月，国家医疗产品管理局发布了重组胶原蛋白的行业标准，明确了其质量控制要求、检测指标、检测方法和生物评价。
In December, the NMPA launched a set of standards, further clarifying the evaluation process of recombinant collagen for medical aesthetics use.
12月，NMPA推出了一套标准，进一步明确了用于医学美学用途的重组胶原蛋白的评估过程。
With over 30 years of development, enterprises had broken the technical barrier of producing recombinant collagen, and the sector has witnessed explosive growth.
经过30多年的发展，企业突破了生产重组胶原蛋白的技术壁垒，该行业实现了爆炸式增长。
Sinopharm is the only enterprise in the world to have independently developed four COVID-19 vaccines via three technical platforms－two inactivated vaccines, one genetic recombinant vaccine and one mRNA vaccine.
国药集团是世界上唯一一家通过三个技术平台自主研发4种新冠肺炎疫苗的企业——两种灭活疫苗、一种基因重组疫苗和一种mRNA疫苗。
Sinopharm is the only enterprise in the world that has independently developed four COVID-19 vaccines via three technical platforms -- two inactivated vaccines, one genetic recombinant vaccine and one mRNA vaccine.
国药集团是全球唯一一家通过两种灭活疫苗、一种基因重组疫苗和一种mRNA疫苗三大技术平台自主研发四种新冠肺炎疫苗的企业。
Beijing-based YishengBio Co Ltd announced during the fair that its PIKA recombinant COVID-19 vaccine, an innovative prophylactic and therapeutic vaccine candidate against multiple SARS-CoV-2 variants, has won clinical trial approval from health authorities in the United Arab Emirates to treat patients with mild to moderate SARS-CoV-2 infections.
在北京举行的展览期间，总部位于北京的YishengBio公司宣布，其PIKA重组COVID-19疫苗，一种针对多种SARS-CoV-2变异株的创新预防和治疗性疫苗候选产品，已获得阿联酋卫生当局的临床试验批准，用于治疗轻度至中度SARS-CoV-2感染的患者。
The agreements said YishengBio will conduct clinical trials in the UAE and Serbia for its PIKA recombinant vaccine for both COVID-19 prevention and treatment.
根据协议,YishengBio(亦称"谊生源")将在阿联酋和塞尔维亚开展PIKA重组新冠疫苗的临床试验,该疫苗将用于预防和治疗COVID-19。
The bioscience subsidiary of State-owned healthcare company Sinopharm, CNBG has been conducting research and development in different types of COVID-19 vaccines via inactivated, recombinant and mRNA technologies.
国药集团旗下的生物科学子公司CNBG一直在通过灭活、重组和mRNA技术研究和开发不同类型的COVID-19疫苗。这里将英文句子翻译成